Records containing: Hereditary Hemorrhagic Telangiectasia
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-10-27A Phase II/III Randomized, Placebo Controlled, Double Blind Study to Evaluate the Effects of up to 24 Weeks of Low Dose Pazopanib on Hereditary Hemorrhagic Telangiectasia Related Epistaxis and Anemia
-
CLINICAL_TRIALS study results posted · 2026-06-04Sirolimus for Nosebleeds in HHT: A Phase II Pilot Study
-
CLINICAL_TRIALS study record update · 2026-04-24Novel Ultra-low-dose Chest CT Technique to Screen for Pulmonary Arteriovenous Malformations in Pediatric Patients With Hereditary Hemorrhagic Teleangiectasia
-
CLINICAL_TRIALS study record update · 2026-04-22Hereditary Hemorrhagic Telangiectasia (HHT) Research Outcomes Registry
-
CLINICAL_TRIALS study record update · 2026-04-22Cerebral Hemorrhage Risk in Hereditary Hemorrhagic Telangiectasia (RDCRN# 6203, Protocol Version Date 07Jan10)
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-04-03InsigHHT: A Phase 1/2, Randomized, Double-blind, Placebo-controlled, 2-part Study of the Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of Single Dose ALN-6400 in Adult Healthy Volunteers and Multiple Dose ALN-6400 in Adult Patients With Hereditary Hemorrhagic Telangiectasia (HHT)
-
CLINICAL_TRIALS study record update · 2026-03-27A Phase 2 Study of Bevacizumab for Chronic Bleeding and Iron Deficiency Anemia in Hereditary Hemorrhagic Telangiectasia (Trial Using Systemic Bevacizumab to Treat HHT, TrUST-HHT)
-
CLINICAL_TRIALS study record update · 2026-03-19A Phase II/III Randomized, Placebo Controlled, Double Blind Study to Evaluate the Effects of up to 24 Weeks of Low Dose Pazopanib on Hereditary Hemorrhagic Telangiectasia Related Epistaxis and Anemia
-
CLINICAL_TRIALS study record update · 2025-12-19Evaluation of the Value of Measuring Pulmonary Arterial Pressures During Exercise in Hereditary Haemorrhagic Telangiectasia Patients With Hepatic Involvement - Pilot Study
-
CLINICAL_TRIALS study record update · 2025-08-14Cardiac Observational Study of Patients With Hereditary Hemorrhagic Telangiectasia
-
CLINICAL_TRIALS study record update · 2025-06-13CHORUS: Comprehensive HHT (Hereditary Hemorrhagic Telangiectasia) Outcomes Registry of the United States
-
CLINICAL_TRIALS study record update · 2025-04-09Prospective Study of Antiplatelet and Anticoagulation Therapy in Hereditary Haemorrhagic Telangiectasia
-
CLINICAL_TRIALS study record update · 2025-04-01Tacrolimus Trial for Hereditary Hemorrhagic Telangiectasia (HHT)
-
CLINICAL_TRIALS study record update · 2025-03-30Influence of Telangiectasia and Anemia on the Well-being and Quality of Life of Patients With Hereditary Hemorrhagic Telangiectasia (HHT).
-
CLINICAL_TRIALS study record update · 2025-03-17Genotype-phenotype Association Study of ENG and ACVRL1 Genes in the Inflammatory and Endothelial Response in Hereditary Hemorrhagic Telangiectasia (HHT)
-
CLINICAL_TRIALS study record update · 2025-02-27Low-dose Sirolimus for Nosebleeds in HHT: a Phase II Pilot Study
-
CLINICAL_TRIALS study record update · 2024-12-06Influence of Hypoxic Induced Factors in Patients With Hereditary Hemorrhagic Telangiectasia (HHT)
-
CLINICAL_TRIALS study record update · 2024-04-18A Multi-Site Tissue Repository Providing Annotated Biospecimens for Approved Investigator-Directed Biomedical Research Initiatives
-
CLINICAL_TRIALS study record update · 2023-09-28Hypoxemia, Dyspnea, and Exercise Tolerance in Patients With Pulmonary Arteriovenous Malformations
-
CLINICAL_TRIALS study record update · 2023-09-21Topical Anti-angiogenic Therapy for Telangiectasia in HHT: Proof of Concept
-
CLINICAL_TRIALS study record update · 2023-03-02Counseling Intervention in Hereditary Hemorrhagic Telangiectasia in the COVID Era.
-
CLINICAL_TRIALS study record update · 2022-09-08An Open-label, Non-randomized Study of the Efficacy of Pazopanib for the Treatment of Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)
-
CLINICAL_TRIALS study record update · 2022-06-14Study of the Efficacy of Propranolol for the Management of Epistaxis in Hereditary Hemorrhagic Telangiectasia Patients
-
CLINICAL_TRIALS study record update · 2022-04-01Nationwide Awareness Campaign and Call for Dental Screening for HHT in Germany
-
CLINICAL_TRIALS study record update · 2021-08-24Efficacy of a Timolol Gel in the Care for Epistaxis in Patients With Hereditary Hemorrhagic Telangiectasia: A Double-Blinded, Randomized Controlled Trial